Literature DB >> 23919771

Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers.

Shaun M Frost1, Yogesan Kanagasingam, Hamid R Sohrabi, Kevin Taddei, Randall Bateman, John Morris, Tammie Benzinger, Alison Goate, Colin L Masters, Ralph N Martins.   

Abstract

CONTEXT: Alzheimer's disease (AD) is usually only diagnosed many years after pathology begins. Earlier detection would allow emerging interventions to have a greater chance to preserve healthy brain function. A rare form of Alzheimer's disease, caused by autosomal-dominant mutations, affects carriers with 100% certainty and at a younger age specific to their mutation. Studying families with these mutations allows a unique investigation of the temporal sequence of biomarker changes in Alzheimer's disease.
OBJECTIVE: To determine whether the pupil flash response (PFR), previously reported to be altered in sporadic Alzheimer's disease, is different in pre-symptomatic mutation carriers.
DESIGN: Researchers blinded to participant mutation status collected pupil response data from cognitively normal participants in the Dominantly Inherited Alzheimer's Network (DIAN) Study during 2010-2011.
SETTING: The pupil response was examined at the McCusker Alzheimer's Research Foundation in Perth, Western Australia. PARTICIPANTS: Participants were from a single family harboring an Amyloid-Beta Precursor Protein genetic mutation (APPGlu693Gln). Six carriers and six non-carriers were available for pupil testing (age 43.0±8.3 years old, 2 males and 10 females, 4 with hypertension). MAIN OUTCOME MEASURE: Pupil response parameter comparison between mutation carriers and non-carriers.
RESULTS: 75% recovery time was longer in mutation carriers (p<0.0003, ROC AUC 1.000, Sensitivity 100%, Specificity 100%) and percentage recovery 3.5 seconds after stimulus was less in mutation carriers (p<0.006, ROC AUC 1.000, Sensitivity 100%, Specificity 100%).
CONCLUSIONS: PFR changes occur pre-symptomatically in autosomal dominant AD mutation carriers, supporting further investigation of PFR for early detection of AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23919771      PMCID: PMC3879087          DOI: 10.2174/15672050113109990154

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  42 in total

1.  Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.

Authors:  J S FitzSimon; S C Waring; E Kokmen; J W McLaren; R F Brubaker
Journal:  Arch Neurol       Date:  1997-02

2.  The pupillary response to tropicamide in Alzheimer's disease.

Authors:  M Fridh; U Havelius; G Elofsson; B Hindfelt
Journal:  Acta Ophthalmol Scand       Date:  1996-06

3.  Altered pupillary size and darkness and light reflexes in Alzheimer's disease.

Authors:  R Prettyman; P Bitsios; E Szabadi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

4.  Detecting Alzheimer's disease.

Authors:  N Pomara; N Sitaram
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

5.  [Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome].

Authors:  K Kono; M Miyao; S Ishihara; A Takagi; H Ikari; Y Suzuki; A Iguchi
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1996-11

6.  Is videopupillography useful in the diagnosis of Alzheimer's disease?

Authors:  E Ferrario; M Molaschi; L Villa; O Varetto; C Bogetto; R Nuzzi
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

7.  Pupil reaction to light in Alzheimer's disease: evaluation of pupil size changes and mobility.

Authors:  Dimitris F Fotiou; Catherine G Brozou; Anna-Bettina Haidich; Dimitris Tsiptsios; Maria Nakou; Anastasia Kabitsi; Charalambos Giantselidis; Fotis Fotiou
Journal:  Aging Clin Exp Res       Date:  2007-10       Impact factor: 3.636

8.  Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Authors:  John S K Kauwe; Sarah Jacquart; Sumi Chakraverty; Jun Wang; Kevin Mayo; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  Re-evaluation of tropicamide in the pupillary response test for Alzheimer's disease.

Authors:  Atsuhiko Iijima; Munetaka Haida; Norio Ishikawa; Akinori Ueno; Haruyuki Minamitani; Yukito Shinohara
Journal:  Neurobiol Aging       Date:  2003-10       Impact factor: 4.673

10.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.

Authors:  Randall J Bateman; Paul S Aisen; Bart De Strooper; Nick C Fox; Cynthia A Lemere; John M Ringman; Stephen Salloway; Reisa A Sperling; Manfred Windisch; Chengjie Xiong
Journal:  Alzheimers Res Ther       Date:  2011-01-06       Impact factor: 6.982

View more
  11 in total

1.  Machine learning for comprehensive prediction of high risk for Alzheimer's disease based on chromatic pupilloperimetry.

Authors:  Yael Lustig-Barzelay; Ifat Sher; Inbal Sharvit-Ginon; Yael Feldman; Michael Mrejen; Shada Dallasheh; Abigail Livny; Michal Schnaider Beeri; Aron Weller; Ramit Ravona-Springer; Ygal Rotenstreich
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

2.  The pupil constriction to light is associated with cognitive measures in middle-aged and older adults.

Authors:  Yanjun Chen; Scott Hetzel; Alex A Pinto; Adam J Paulsen; Carla R Schubert; Laura M Hancock; Barbara E Klein; Natascha Merten; Karen J Cruickshanks
Journal:  Aging Clin Exp Res       Date:  2022-03-10       Impact factor: 4.481

3.  Contrast Acuity and the King-Devick Test in Huntington's Disease.

Authors:  Ali G Hamedani; Tanya Bardakjian; Laura J Balcer; Pedro Gonzalez-Alegre
Journal:  Neuroophthalmology       Date:  2019-11-25

4.  Refined Frequency Doubling Perimetry Analysis Reaffirms Central Nervous System Control of Chronic Glaucomatous Neurodegeneration.

Authors:  Matthew A Reilly; Analaura Villarreal; Ted Maddess; William Eric Sponsel
Journal:  Transl Vis Sci Technol       Date:  2015-06-08       Impact factor: 3.283

Review 5.  The Eye As a Biomarker for Alzheimer's Disease.

Authors:  Jeremiah K H Lim; Qiao-Xin Li; Zheng He; Algis J Vingrys; Vickie H Y Wong; Nicolas Currier; Jamie Mullen; Bang V Bui; Christine T O Nguyen
Journal:  Front Neurosci       Date:  2016-11-17       Impact factor: 4.677

Review 6.  Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.

Authors:  Ralph N Martins; Victor Villemagne; Hamid R Sohrabi; Pratishtha Chatterjee; Tejal M Shah; Giuseppe Verdile; Paul Fraser; Kevin Taddei; Veer B Gupta; Stephanie R Rainey-Smith; Eugene Hone; Steve Pedrini; Wei Ling Lim; Ian Martins; Shaun Frost; Sunil Gupta; Sid O'Bryant; Alan Rembach; David Ames; Kathryn Ellis; Stephanie J Fuller; Belinda Brown; Samantha L Gardener; Binosha Fernando; Prashant Bharadwaj; Samantha Burnham; Simon M Laws; Anna M Barron; Kathryn Goozee; Eka J Wahjoepramono; Prita R Asih; James D Doecke; Olivier Salvado; Ashley I Bush; Christopher C Rowe; Samuel E Gandy; Colin L Masters
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Morphometric Changes to Corneal Dendritic Cells in Individuals With Mild Cognitive Impairment.

Authors:  Cirous Dehghani; Shaun Frost; Rajiv Jayasena; Christopher Fowler; Colin L Masters; Yogesan Kanagasingam; Haihan Jiao; Jeremiah K H Lim; Holly R Chinnery; Laura E Downie
Journal:  Front Neurosci       Date:  2020-12-09       Impact factor: 4.677

8.  Pupil size as an indicator of cognitive activity in mild Alzheimer's disease.

Authors:  Mohamad El Haj; Guillaume Chapelet; Ahmed A Moustafa; Claire Boutoleau-Bretonnière
Journal:  EXCLI J       Date:  2022-01-17       Impact factor: 4.068

Review 9.  Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.

Authors:  Fatimah Zara Javaid; Jonathan Brenton; Li Guo; Maria F Cordeiro
Journal:  Front Neurol       Date:  2016-04-19       Impact factor: 4.003

Review 10.  Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease.

Authors:  Ajay K Singh; Shilpa Verma
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.